New clinical score for disease activity at diagnosis in Langerhans cell histiocytosis

BACKGROUND: The clinical presentation and course of Langerhans cell histiocytosis (LCH) are variable, ranging from an isolated, spontaneously remitting bone lesion to multisystem disease with risk organ involvement. Treatment of LCH ranges from a wait-and-see attitude to intensive multidrug therapy...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Choi, Won-ik, Jeong, You Cheol, Kim, Sun Young, Kim, So Dam, Pribis, John Paul, Kim, Hee-Jin, Koh, Kyung-Nam, Im, Ho-Joon, Lee, Young-Ho, Seo, Jong-Jin
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2011
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3208202/
https://ncbi.nlm.nih.gov/pubmed/22065974
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5045/kjh.2011.46.3.186
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia